Expression of G-CSF and GM-CSF in human meningiomas correlates with increased tumor proliferation and vascularization

Journal of Neuro-Oncology

Volumn 68, Issue 2, 2004, Pages 131-140

  Braun, Bernhard ^a   Lange, Manfred ^b   Oeckler, Reinhard ^b   Mueller, Margareta M ^c  

^a Hospital Darmstadt   (Germany)

^b Hospital Villingen Schwenningen   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

G CSF; GM CSF; Ki 67; Meningiomas; Proliferation; Tumor progression

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; PHENOTYPE; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VASCULARIZATION; CELL DIVISION; METABOLISM; MIDDLE AGED; MITOSIS INDEX; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MITOTIC INDEX; NEOVASCULARIZATION, PATHOLOGIC;

EID: 3242883265     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000027751.87894.f0     Document Type: Article

References (56)

1. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3: 255-268, 1993
2. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM: Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21: 1455-1465, 1997
3. Wilson CB: Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C Schneider Lecture. J Neurosurg 81: 666-675, 1994
4. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H, Kirino T: Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol (Berl) 91: 504-510, 1996
5. Yao YT: Clinicopathologic analysis of 615 cases of meningioma with special reference to recurrence. J Formos Med Assoc 93: 145-152, 1994
6. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP et al.: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6: 180-184, 1994
7. Detta A, Kenny BG, Smith C, Logan A, Hitchcock E: Correlation of proto-oncogene expression and proliferation in meningiomas. Neurosurgery 33: 1065-1074, 1993
8. Riva P, Larizza L: Expression of c-sis and c-fos genes in human meningiomas and neurinomas. Int J Cancer 51: 873-877, 1992
9. Aaronson SA: Growth factors and cancer. Science 254: 1146-1153, 1991
10. Shamah SM, Alberta JA, Giannobile WV, Guha A, Kwon YK, Carroll RS, Black PM, Stiles CD: Detection of activated platelet-derived growth factor receptors in human meningioma. Cancer Res 57: 4141-4147, 1997
11. Carroll RS, Black PM, Zhang J, Kirsch M, Percec I, Lau N, Guha A: Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg 87: 315-323, 1997
12. Lichtor T, Kurpakus MA, Gurney ME: Expression of insulin-like growth factors and their receptors in human meningiomas. J Neuro-Oncol 17: 183-190, 1993
13. Todo T, Adams EF, Fahlbusch R, Dingermann T, Werner H: Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor. J Neurosurg 84: 852-858, 1996
14. Nordqvist AC, Mathiesen T: Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J Neuro-Oncol 57: 19-26, 2002
15. Sanson M, Cornu P: Biology of meningiomas. Acta Neurochir (Wien) 142: 493-505, 2000
16. Goldsmith BJ, Wara WM, Wilson CB, Larson DA: Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80: 195-201, 1994
17. Marks SM, Whitwell HL, Lye RH: Recurrence of meningiomas after operation. Surg Neurol 25: 436-444, 1986
18. Schrell UM, Rittig MG, Anders M, Koch UH, Marschalek R, Kiesewetter F, Fahlbusch R: Hydroxyrea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 86: 840-844, 1997
19. MacManus MP, Clarke J, McCormick D, Abram WP: Use of recombinant granulocyte-colony stimulating factor to treat neutropenia occurring during craniospinal irradiation. Int J Radiat Oncol Biol Phys 26: 845-850, 1993
20. Marks LB, Halperin EC: The use of G-CSF during craniospinal irradiation. Int J Radiat Oncol Biol Phys 26: 905-906, 1993
21. Papadopoulos KP, Balmaceda C, Fetell M, Kaufman E, Vahdat LT, Bruce J, Sisti M, Isaacson S, De LaPaz R, Savage DG, Troxel A, Amman KH, Hesdorffer CS: A phase. I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors. J Neuro-Oncol 44: 155-162, 1999
22. American Society of Clinical Oncology: American Society of Clinical Oncology recommendations for the use of hematopoietic colony stimulating factors: evidence based clinical practice guidelines. J Chn Oncol 12: 2471-2508, 1994
23. Mayordomo JI, Rivera F, Diaz-Puente MT, Lianes P, Colomer R, Lopez-Brea M, Lopez E, Paz-Ares L, Hitt R, Garcia-Ribas I: Improving treatment of chemotherapy-induced neutropenic fever by administration of colony stimulating factors. J Natl Cancer Inst 87: 803-808, 1995
24. Rampling R, Steward W, Paul J, Macham MA, Harvey E, Eckley D: rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU. Br J Cancer 69: 541-545, 1994
25. Williams ME, Quesenberry PJ: Hematopoietic growth factors. Hematol Pathol 6: 105-124, 1992
26. Demetri GD, Griffin JD: Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791-2808, 1991
27. Shimoda K, Okamura S, Harada N, Kondo S, Okamura T, Niho Y: Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest 91: 1310-1313, 1993
28. Tkatch LS, Tweardy DJ: Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function, Lymphok Cytok Res 6: 477-488, 1993
29. Kastelstein RA, Shanafelt AB: GM-CSF receptor: Interactions and activation. Oncogene. 8: 231-236, 1993
30. Nicola NA, Wycherley K, Boyd AW, Layton JE, Gary D, Metcalf D: Neutralizing and nonneutralizing monoclonal antibodies to the human granulocyte-macrophage. colony-stimulating factor receptor α-chain. Blood 82: 1724-1731, 1993
31. Bussolino F, Ziche M, Wang J, Alessi D, Mobidelli L, Cremona O, Bosai A, Marchisio P, Mantovani A: In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Inves 87: 986-995, 1991
32. Hamilton JA, Piccoli DS, Cebon J, Layton JE, Rathanaswani P, McColl SR, Leizer T: Cytokine regulation of colony-stimulating factor (CSF) production in cultured human synovial fibroblasts II. Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulocyte-CSF production. Blood 79: 1413-1419, 1992
33. Stoof TJ, Boorsma DM, Nickoloff BJ: Keratinocytes and immunological cytokines. In: Leigh I and Watt F (eds) The Keratinocyte Handbook. Cambridge University Press, pp 363-399, 1994
34. Dedhar S, Gaboury L, Galloway P, Eaves C: Human granulocyte-macrophage colony stimulating factor is a growth factor active on a variety of cell types of nonhematopoietic origin. Proc Natl Acad Sci USA 85: 9253-9257, 1988
35. Olaniran AK, Baker BS, Garioch JJ, Powles AV, Fry L: A comparison of the stimulatory effects of cytokines on normal and psoriatic keratinocytes in vitro. Arch Dermatol Res 2877: 231-236, 1995
36. Szabowski A, Maas-Szabowski N, Andrecht S, Kolbus A, Schorpp-Kistner M, Fusenig NE, Angel P: C-Jun and JunB antagonistically regulate expression of cytokines controlling mesenchymal-epidermal crosstalk. Cell 103: 745-755, 2000
37. Mueller MM, Herold-Mende CC, Riede D, Lange M, Steiner H-H, Fusenig NE: Autocrine growth regulation by G-CSF and GM-CSF in human gliomas with tumor progression. Am J Pathol 155: 1557-1567, 1999
38. Foulke RS, Marshall MH, Trotta PP, Von Hoff DD: In vitro assessment of the effects of granulocyte-macrophage colony stimulating factor on primary human tumors and derived cell lines. Cancer Res 50: 6264-6267, 1990
39. Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Symann ML: Transcription of genes encoding granulocyte-macrophage. colony-stimulating factor, interleukin-3, and interleukin-6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines. Cancer Res 53: 3139-3144, 1993
40. MacManus MP, McCormick D, Trimble A, Abram WP: Value of granulocyte colony stimulating factor in radiotherapy induced neutropenia: clinical and laboratory studies. Eur J Cancer 31A: 302-307, 1995
41. Mueller MM, Fusenig NE: Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int J Cancer 83: 780-789, 1999
42. Pei X-H, Nakanishi Y, Takayama K, Yatsunami J, Bai F, Kawasaki M, Wakamatsu K, Tsuruta N, Mizuno K, Hara N: Granulocyte-colony stimulating factor promotes invasion by human lung cancer cell lines in vitro. Clin Exp Metastasis 14: 351-357, 1996
43. Tsuzuki H, Fujieda S, Sunaga H, Noda I, Saito H: Expression of granulocyte colony stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma. Cancer Res 58: 794-800, 1998
44. Sandberg-Nordquist AC, Peyrard M, Petterson H, Mathiesen T, Collins VP, Dumanski JP, Schalling M: A high ratio of insulin-like growth factor/insulin like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas. Cancer Res 57: 2611-2614, 1997
45. Lehmann EL: Nonparametrics: Statistical Methods Based on Ranks. Holden-Day, Inc., San Francisco, 1975
46. Louis DN, Budka H, von Deimling A: Meningeal tumors. In: Kleihues P, Burger PC, Scheithauer BW (eds) Histological Typing of Tumors of the Central Nervous System, Vol. 2 Springer, Heidelberg, 1993
47. Baba M, Hasegawa H, Nakayabu M, Shimizu N, Suszuki S, Kamada N, Tani K: Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: The presence of autocrine growth control by G-CSF. Am J Hematol 49: 207-215, 1995
48. Horii A, Shimamura K, Honjo Y, Mitani K, Miki T, Takashima S, Yoshida J: Granulocyte colony stimulating factor-producing tongue carcinoma. Head and Neck 19: 351-356, 1997
49. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M: Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56: 853-857, 1994
50. Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J: Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 55: 3438-3443, 1995
51. Noda I, Fujieda S, Ohtsubo T, Tsuzuki H, Tanaka N, Sunaga H, Saito H: Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines. Int J Cancer 80: 78-84, 1999
52. Safarians S, Rivera SP, Sternlicht MD, Naeim F, Barsky SH: Ectopic G-CSF expression in human melanoma lines marks a trans-dominant pathway of tumor progression. Am J Pathol 150: 949-962, 1997
53. Tachibana M, Murai M: G-CSF production in human bladder cancer and its ability to promote autocrine growth: a review. Cytokines Cell Mol Ther 4: 113-120, 1998
54. Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W: Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wien) 137: 174-181, 1995
55. Simoca I, Olarescu AA, Jipescu I, Lisievici M: Postoperative outcome of intracranial meningiomas; long-term prognosis. Rom. J Neurol Psychiatry 32: 237-251, 1994
56. Kyo S, Kanaya T, Takakura M, Inoue M: A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6. Gynecol Oncol 78(3 Pt 1): 383-387, 2000